At a meeting of the Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the majority of panel members voted against the approval of sotagliflozin (Zynquista™) ...
A plugin to launch applications from the panel. By default it is empty and displays a message "Drop application icons here". Applications need to be available in panel's main menu and can be included ...
She has over 20 years of experience using a ketogenic diet to treat epilepsy in children, and more recently in research for adults with bipolar disorder. Metabolic dysfunction is an established ...
Opens in a new tab or window An FDA panel on Thursday recommended against ... With a vote of 11-3, the Endocrinologic and Metabolic Drugs Advisory Committee said the benefits of the dual SGLT1 ...
Data were limited for patients with eGFR 60, therefore definitive conclusions on the benefits and risks in this subgroup could not be made. At a meeting of the Food and Drug Administration’s ...